{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:35:48Z","timestamp":1785544548303,"version":"3.56.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mycoplasma pneumoniae pneumonia (MPP) stands as a predominant cause of community-acquired respiratory infections in children. With the increasing prevalence of macrolide-resistant Mycoplasma pneumoniae strains, the therapeutic efficacy of azithromycin monotherapy has become a growing concern in clinical practice. Montelukast sodium, a selective leukotriene receptor antagonist, has emerged as a promising adjunctive agent, as it can effectively alleviate airway inflammation and reduce airway hyperresponsiveness. This meta-analysis was designed to systematically evaluate the efficacy and safety of azithromycin sequential therapy combined with montelukast in the management of pediatric MPP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted across PubMed, Embase, Web of Science Core Collection, Wanfang Data, Variant Impact Predictor database, and Chinese National Knowledge Infrastructure from the establishment of each database up to November 2025. Eligible studies were randomized controlled trials (RCTs) that compared azithromycin sequential monotherapy with azithromycin sequential therapy plus montelukast in pediatric patients diagnosed with MPP. Primary outcome measures included overall clinical efficacy, resolution time of key clinical symptoms (cough, wheezing, pulmonary rales, and fever), and the incidence of adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirty-six RCTs involving 3450 pediatric patients (1726 in the combination group and 1724 in the azithromycin group) met the inclusion criteria. Compared with azithromycin sequential therapy, combination therapy significantly improved overall clinical efficacy (odds ratio\u2005=\u20054.75, 95% confidence interval [CI]: 3.70\u20136.10). The addition of montelukast also shortened the resolution time of cough (mean difference [MD]\u2005=\u2005\u22123.63, 95% CI: \u22124.27 to \u22122.99), wheezing (MD\u2005=\u2005\u22121.48, 95% CI: \u22121.82 to \u22121.14), pulmonary rales (MD\u2005=\u2005\u22122.06, 95% CI: \u22122.54 to \u22121.57), and fever (MD\u2005=\u2005\u22121.43, 95% CI: \u22121.89 to \u22120.96). No significant difference in adverse event rates was observed between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Azithromycin sequential therapy combined with montelukast may provide additional therapeutic benefits for the treatment of pediatric MPP, characterized by higher overall clinical efficacy and more rapid resolution of clinical symptoms, without a statistically significant increase in short-term adverse events. Despite the encouraging findings, the included studies were predominantly single-center trials with moderate methodological quality. Therefore, well-designed, large-scale, multicenter RCTs are urgently needed to validate these results and provide more reliable evidence for guiding clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050050","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:28:48Z","timestamp":1785533328000},"page":"e50050","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of azithromycin sequential therapy combined with montelukast in the treatment of pediatric mycoplasma pneumonia: A meta-analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Mingming","family":"Wu","sequence":"first","affiliation":[{"name":"Pediatrics Department, Jiangcun Subdistrict Community Health Service Center, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Chen","sequence":"additional","affiliation":[{"name":"General Practice Department, Jiangcun Subdistrict Community Health Service Center, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0050-4217","authenticated-orcid":false,"given":"Haihong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Science and Education, Jiangcun Subdistrict Community Health Service Center, Hangzhou, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260731","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10096-025-05360-w","article-title":"Epidemiological characteristics of Chlamydial infection in hospitalized children in China: a nationwide retrospective study.","volume":"45","author":"Zheng","year":"2026","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R2-20260731","doi-asserted-by":"crossref","first-page":"1506621","DOI":"10.3389\/fmed.2025.1506621","article-title":"Efficacy and safety analysis of montelukast sodium added on azithromycin in the treatment of Mycoplasma pneumoniae pneumonia in children.","volume":"12","author":"Liang","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R3-20260731","first-page":"2649","article-title":"Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children.","volume":"20","author":"Chen","year":"2020","journal-title":"Exp Ther Med"},{"key":"R4-20260731","first-page":"1","article-title":"Influence of montelukast combined with methylprednisolone on liver function, platelet count, eosinophil count, and myocardial enzymes in bronchopneumonia children with wheezing.","volume":"86","author":"Yuan","year":"2025","journal-title":"Br J Hosp Med"},{"key":"R5-20260731","first-page":"45","article-title":"Eosinophilic granulomatosis with polyangiitis induced by montelukast.","volume":"63","author":"Grama","year":"2024","journal-title":"Acta Clin Croat"},{"key":"R6-20260731","first-page":"109","article-title":"Meta-analysis of the efficacy of montelukast sodium combined with azithromycin in the treatment of Mycoplasma pneumoniae pneumonia in children.","volume":"43","author":"Tao","year":"2022","journal-title":"J Qiqihar Med Univ"},{"key":"R7-20260731","first-page":"919","article-title":"Efficacy of azithromycin combined with montelukast in the treatment of pediatric Mycoplasma pneumoniae pneumonia and its effects on C-reactive protein and IgE.","volume":"13","author":"Yang","year":"2013","journal-title":"Chin Remedies Clin"},{"key":"R8-20260731","first-page":"104","article-title":"Clinical efficacy analysis of montelukast sodium in the intervention treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"7","author":"Zhang","year":"2013","journal-title":"Chin J Mod Drug Appl"},{"key":"R9-20260731","first-page":"132","article-title":"Clinical efficacy observation of azithromycin combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"5","author":"Chen","year":"2014","journal-title":"Contemp Med"},{"key":"R10-20260731","first-page":"78","article-title":"Clinical observation of azithromycin combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"9","author":"Liao","year":"2014","journal-title":"China Health Ind"},{"key":"R11-20260731","first-page":"2092","article-title":"Efficacy analysis of azithromycin sequential therapy combined with montelukast in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"11","author":"Wang","year":"2014","journal-title":"J Clin Pulm Med"},{"key":"R12-20260731","first-page":"41","article-title":"Efficacy of azithromycin combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia and its effect on serum C-reactive protein level.","volume":"1","author":"Zhu","year":"2015","journal-title":"J Clin Exp Med"},{"key":"R13-20260731","first-page":"24","article-title":"Treatment of children with Mycoplasma pneumonia effect and immunoglobulin protein levels and C reactive protein in the influence of azithromycin combined with montelukast sodium.","volume":"37","author":"Chen","year":"2016","journal-title":"J Mudanjiang Med Univ"},{"key":"R14-20260731","first-page":"601","article-title":"Clinical efficacy evaluation of azithromycin combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"13","author":"Huang","year":"2016","journal-title":"Anti Infect Pharm"},{"key":"R15-20260731","first-page":"83","article-title":"Efficacy of azithromycin combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia and its effect on serum CRP.","volume":"25","author":"Tan","year":"2017","journal-title":"China Med Eng"},{"key":"R16-20260731","first-page":"60","article-title":"Effect of azithromycin combined with montelukast sodium on serum CRP level in children with Mycoplasma pneumoniae pneumonia.","volume":"34","author":"Dai","year":"2018","journal-title":"Chin Community Physicians"},{"key":"R17-20260731","first-page":"794","article-title":"Clinical study of montelukast sodium combined with azithromycin in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"39","author":"Liu","year":"2018","journal-title":"Sichuan Med J"},{"key":"R18-20260731","first-page":"342","article-title":"Clinical observation of azithromycin combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"29","author":"Wang","year":"2018","journal-title":"Chin J Matern Child Health Res"},{"key":"R19-20260731","first-page":"118","article-title":"Observation on the effect of montelukast sodium combined with azithromycin sequential therapy in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"38","author":"Wang","year":"2018","journal-title":"Clin Med"},{"key":"R20-20260731","first-page":"1071","article-title":"Effects of azithromycin combined with montelukast sodium on immune function and pulmonary function in children with Mycoplasma pneumoniae pneumonia.","volume":"37","author":"Zhou","year":"2018","journal-title":"Herald Med"},{"key":"R21-20260731","first-page":"90","article-title":"Effect of azithromycin combined with montelukast sodium on NOD-like receptor protein-3 inflammasome pathway in children with Mycoplasma pneumoniae pneumonia.","volume":"27","author":"Duan","year":"2019","journal-title":"China Med Eng"},{"key":"R22-20260731","first-page":"118","article-title":"Clinical efficacy evaluation of azithromycin combined with montelukast in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"37","author":"Fan","year":"2019","journal-title":"J Prev Med Chin PLA"},{"key":"R23-20260731","first-page":"51","article-title":"Efficacy of azithromycin combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia and its effect on serum C-reactive protein level.","volume":"9","author":"Jing","year":"2019","journal-title":"China Med Pharm"},{"key":"R24-20260731","first-page":"141","article-title":"Observation on the effect of azithromycin combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia and its influence on inflammatory response and CRP level.","volume":"6","author":"Li","year":"2019","journal-title":"Electron J Clin Med Lit"},{"key":"R25-20260731","first-page":"2225","article-title":"Efficacy analysis of montelukast sodium combined with azithromycin sequential therapy in the treatment of children with Mycoplasma pneumonia.","volume":"31","author":"Fu","year":"2020","journal-title":"Mod Diagn Treat"},{"key":"R26-20260731","first-page":"907","article-title":"Effect analysis of montelukast sodium combined with azithromycin in the treatment of children with Mycoplasma pneumoniae pneumonia.","volume":"33","author":"Zhi","year":"2020","journal-title":"J Math Med"},{"key":"R27-20260731","first-page":"11","article-title":"Azithromycin sequential therapy combined with montelukast sodium in the treatment of pediatric mycoplasma pneumonia and its effects on levels of CRP, PCT, IL-13 and IL-17A in children.","volume":"4","author":"Liu","year":"2020","journal-title":"Electron J Mod Med Health Res"},{"key":"R28-20260731","first-page":"115","article-title":"Effects of azithromycin sequential therapy combined with montelukast sodium on immunoglobulins and inflammatory factors in children with mycoplasmal pneumonia.","volume":"4","author":"Lu","year":"2020","journal-title":"Electron J Mod Med Health Res"},{"key":"R29-20260731","first-page":"36","article-title":"Clinical efficacy and safety of azithromycin sequential therapy combined with montelukast sodium in the treatment of children with mycoplasma pneumonia.","volume":"13","author":"Lin","year":"2020","journal-title":"J Clin Ration Drug Use"},{"key":"R30-20260731","first-page":"213","article-title":"Clinical effect of azithromycin sequential therapy combined with montelukast sodium in the treatment of children with Mycoplasma pneumoniae pneumonia (MPP) and its influence on immune indexes, serum inflammatory factors and pulmonary function.","volume":"17","author":"Zhang","year":"2021","journal-title":"Kangyi"},{"key":"R31-20260731","first-page":"16","article-title":"Analysis of the effect of azithromycin sequential therapy combined with montelukast sodium on CRP and PCT in children with mycoplasma pneumoniae pneumonia.","volume":"11","author":"Wang","year":"2021","journal-title":"Kangyi"},{"key":"R32-20260731","first-page":"118","article-title":"Clinical effect of azithromycin sequential therapy combined with montelukast sodium in the treatment of children with mycoplasma pneumoniae pneumonia.","volume":"23","author":"Yi","year":"2021","journal-title":"Health Home"},{"key":"R33-20260731","first-page":"1","article-title":"Clinical efficacy and safety observation of azithromycin sequential therapy combined with montelukast sodium in the treatment of children with mycoplasma pneumoniae pneumonia.","volume":"14","author":"Guo","year":"2022","journal-title":"Matern Child World"},{"key":"R34-20260731","first-page":"58","article-title":"Clinical observation of montelukast sodium tablets combined with azithromycin on mycoplasma pneumoniae pneumonia in children.","volume":"34","author":"Cai","year":"2022","journal-title":"Tianjin Pharm Sci"},{"key":"R35-20260731","first-page":"82","article-title":"Clinical study on montelukast sodium combined with azithromycin sequential therapy in the treatment of children with mycoplasmal pneumonia.","volume":"44","author":"Qian","year":"2023","journal-title":"Yunnan Med J"},{"key":"R36-20260731","first-page":"145","article-title":"Efficacy analysis of montelukast sodium combined with azithromycin sequential therapy in the treatment of children with mycoplasma pneumoniae pneumonia.","volume":"4","author":"Hou","year":"2023","journal-title":"Diet Sci"},{"key":"R37-20260731","first-page":"105","article-title":"Effect of azithromycin sequential therapy combined with montelukast sodium in the treatment of mycoplasma pneumoniae pneumonia.","volume":"50","author":"Ji","year":"2023","journal-title":"Chin J Pract Med"},{"key":"R38-20260731","first-page":"15","article-title":"Effect of azithromycin sequential therapy combined with montelukast sodium in the treatment of mycoplasma pneumoniae pneumonia.","volume":"3","author":"Zhao","year":"2024","journal-title":"Chin Foreign Med Res"},{"key":"R39-20260731","first-page":"105","article-title":"Efficacy analysis of azithromycin combined with montelukast sodium in the treatment of mycoplasma pneumoniae pneumonia in children.","volume":"43","author":"Guan","year":"2024","journal-title":"Chin Foreign Med"},{"key":"R40-20260731","first-page":"76","article-title":"Clinical effect of montelukast sodium combined with azithromycin sequential therapy in the treatment of children with mycoplasma pneumoniae pneumonia.","volume":"5","author":"Yu","year":"2025","journal-title":"Matern Child World"},{"key":"R41-20260731","first-page":"61","article-title":"Efficacy and safety evaluation of montelukast sodium combined with azithromycin in the treatment of children with mycoplasma pneumoniae pneumonia.","volume":"4","author":"Gao","year":"2025","journal-title":"Technol Health"},{"key":"R42-20260731","first-page":"146","article-title":"Clinical observation of the efficacy of montelukast sodium combined with low-dose azithromycin in the treatment of recurrent lower respiratory tract infections in children.","volume":"48","author":"Han","year":"2025","journal-title":"Heilongjiang Med Sci"},{"key":"R43-20260731","first-page":"7790381","article-title":"Postinfectious bronchiolitis obliterans in children.","volume":"2025","author":"Wan","year":"2025","journal-title":"Can Respir J"},{"key":"R44-20260731","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","article-title":"Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.","volume":"16","author":"Lee","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R45-20260731","doi-asserted-by":"crossref","first-page":"154402","DOI":"10.1016\/j.phymed.2022.154402","article-title":"Efficacy and safety of reduning injection combined with azithromycin in the treatment of mycoplasma pneumonia among children: a systematic review and meta-analysis.","volume":"106","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"R46-20260731","first-page":"5256","article-title":"Clinical effect of treating secondary asthma attacks of children Mycoplasma pneumoniae with combined therapy of montelukast and azithromycin.","volume":"20","author":"Gong","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R47-20260731","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41522-025-00859-8","article-title":"Multi-omics analysis of host airway responses in pediatric Mycoplasma pneumoniae pneumonia reveals potential mechanisms of disease exacerbation caused by co-infection.","volume":"11","author":"Li","year":"2025","journal-title":"NPJ Biofilms Microbiomes"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:28:55Z","timestamp":1785533335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":47,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050050","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2026-01-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}